<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733232/" ref="ordinalpos=1939&amp;ncbi_uid=5165997&amp;link_uid=PMC3733232" image-link="/pmc/articles/PMC3733232/figure/F3/" class="imagepopup">Figure 3. Crosstalk between the epidermal growth factor (EGF)-Ras- extracellular regulated kinase (Erk)-mitogen-activated protein (MAP) kinase <span class="highlight" style="background-color:">pathway</span> and both the transforming growth factor-β-inducible early response gene TIEG and Smad <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in cancer.  From: TGF?-mediated <span class="highlight" style="background-color:">signaling</span> and transcriptional regulation in pancreatic development and cancer. </a></div><br /><div class="p4l_captionBody">Hypersensitive Ras and its downstream mediator kinase Erk block transforming growth factor-β (TGFβ) signaling through phosphorylation of the receptor Smads S2/S3 and thereby inhibit the complex formation with Smad4. In addition, EGF-activated Erk MAPkinase phosphorylates TIEG2 and thereby antagonizes its transcriptional repression activity through interfering with the binding of the Sin3A corepressor complex.</div></div>